Information Overload: With the rise in popularity, there's a lot of information circulating, especially online
210 Mazdutide represents the most recent advancement in GLP-1/GCG dual receptor agonists
Ziyad Al-Aly, a clinical epidemiologist at WashU Medicine and Chief of Research and Development Service at the VA Saint Louis Health Care System
Chu T, Wu M, Hoellbacher B, de Almeida GP, Wurmser C, Berner J, et al
Why it matters: A broader mechanism does not automatically mean a safer or better treatment
Glucagon-like peptide-1 (GLP-1) agonists are increasingly popular injectable medications that are highly effective in helping patients lose weight and reduce body fat